BETHANECHOL CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Bethanechol Chloride patents expire, and when can generic versions of Bethanechol Chloride launch?
Bethanechol Chloride is a drug marketed by Able, Actavis Elizabeth, Amneal Pharm, Ascot, Chartwell Rx, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Co Inc, Sandoz, Sun Pharm Inds Inc, Upsher Smith Labs, Watson Labs, and Wockhardt. and is included in forty-four NDAs.
The generic ingredient in BETHANECHOL CHLORIDE is bethanechol chloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bethanechol Chloride
A generic version of BETHANECHOL CHLORIDE was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETHANECHOL CHLORIDE?
- What are the global sales for BETHANECHOL CHLORIDE?
- What is Average Wholesale Price for BETHANECHOL CHLORIDE?
Summary for BETHANECHOL CHLORIDE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 44 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,356 |
| DailyMed Link: | BETHANECHOL CHLORIDE at DailyMed |
Recent Clinical Trials for BETHANECHOL CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rajavithi Hospital | Phase 4 |
Pharmacology for BETHANECHOL CHLORIDE
| Drug Class | Cholinergic Muscarinic Agonist |
| Mechanism of Action | Cholinergic Muscarinic Agonists |
Medical Subject Heading (MeSH) Categories for BETHANECHOL CHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for BETHANECHOL CHLORIDE
US Patents and Regulatory Information for BETHANECHOL CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 040897-002 | Apr 22, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett Co Inc | BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 040677-003 | Mar 27, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 085230-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt | BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 040533-001 | Sep 29, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
